Imaging Techniques in MRI

NCT01130545 | Recruiting

• 2 other identifiers: 10011510-CC-0115
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

Background: \- Magnetic resonance imaging (MRI) scans must be performed according to specified sets of parameters that provide optimal images of each organ and each area of the body. These scanning parameters are often specific to the institution or organization at which they are employed, and may also depend on the manufacturer of the MRI scanning equipment. Because MRI scanning equipment is always being updated and upgraded, researchers are interested in developing new and optimized scanning parameters for MRI scans. Objectives: \- To improve current methods and develop new techniques for magnetic resonance imaging. Eligibility:

• Individuals 18 years of age and older who are either volunteers or current NIH protocol participants.
• Participants must not have any medical history factors (e.g., extreme claustrophobia, history of metal implants) that would prevent them from receiving MRI scans. Design:
• Participants will have at least one MRI scan that will last from 20 minutes to 2 hours (most scans will last between 45 and 90 minutes). The total time commitment for most visits will be approximately 4 hours from start to finish.
• Some MRI techniques require standard monitoring equipment or specific procedures during the scanning, such as an electrocardiogram.
• Participants will have blood samples taken at the time of the scan. Some MRI studies will require the use of a contrast agent that will be administered during the scan.
• Volunteers may be asked to return for additional MRI scans over the course of a few years. Follow-up scans may be done on the same part of the body or on different parts of the body. No more than one MRI scan will be performed in any 4-week period for this protocol....

Conditions

Cardiac Risk Factors; Healthy; Healthy Volunteers

Keywords

Healthy Volunteer; Magnetic Resonance Imaging; Gadolinium; Natural History; HV

Outcome Measures

Primary Outcomes (1)

• To refine current methodology and develop new techniques for MRI

  To refine current methodology and develop new techniques for magnetic resonance imaging in the general population.

  End of study

Study Arms (1)

Volunteers

Volunteers (maybe Volunteers, NIH employee and current NIH protocol participants)

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Volunteers (maybe Volunteers, NIH employee and current NIH protocol participants)

You may qualify if:

• A. Volunteer individuals
• B. Lab Eligibility parameters (for contrast scans within 4 weeks of gadolinium injection):
• C. Creatinine below upper normal limit
• D. eGFR \>= 60 mL/min/1.73m2
• E. Age \>= 60 or history of renal disease: test GFR within 1 week prior to contrast
• F. Willing to travel to the NIH for follow-up visits.
• G. 18 years old
• H. Able to understand and sign informed consent
• I. No MRI scan with gadolinium injection in the last 6 months under this protocol.

You may not qualify if:

• A. Implanted metal clips or wires of the type which may concentrate radiofrequency fields or cause tissue damages from twisting in a Magnetic field. Examples:
• Aneurysm clip, implanted neural stimulator,
• Implanted cardiac pacemaker, defibrillator, or certain other implanted electrical or metallic devices,
• Cochlear implant, ocular foreign body (metal shavings),
• Any implanted device (pumps, infusion devices, etc.),
• Shrapnel injuries,
• History of metal in head or eyes or other parts of the body.
• B. Pregnant women
• C. Paralyzed hemidiaphragm
• D. Over 500 lbs and/or a body circumference that prevents the study subject from laying flat in the scanner
• E. Surgery of uncertain type
• F. Untreatable claustrophobia otherwise requiring anesthesia.
• G. Any contraindications that the Physician identifies from the subject, MRI Safety Questionnaire, and/or History and Physical.
• A. Allergy to gadolinium for scans using contrast; will be eligible for non-contrast scans.
• B. Acute renal failure, renal transplant, dialysis and renal failure individuals (eGFR \<60 mL/min/1.73m2 and/or clinically diagnosed).

Sponsors & Collaborators

• National Institutes of Health Clinical Center (CC): lead

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

RECRUITING

Related Publications (5)

• Mattay VS, Weinberger DR, Barrios FA, Sobering GS, Kotrla KJ, van Gelderen P, Duyn JH, Sexton RH, Moonen CT, Frank JA. Brain mapping with functional MR imaging: comparison of gradient-echo--based exogenous and endogenous contrast techniques. Radiology. 1995 Mar;194(3):687-91. doi: 10.1148/radiology.194.3.7862963.

  PMID: 7862963 BACKGROUND

• Perez-Rodriguez J, Lai S, Ehst BD, Fine DM, Bluemke DA. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases. Radiology. 2009 Feb;250(2):371-7. doi: 10.1148/radiol.2502080498.

  PMID: 19188312 BACKGROUND

• Frank JA, Mattay VS, Duyn J, Sobering G, Barrios FA, Zigun J, Sexton R, Kwok P, Woo J, Moonen C, et al. Measurement of relative cerebral blood volume changes with visual stimulation by 'double-dose' gadopentetate-dimeglumine-enhanced dynamic magnetic resonance imaging. Invest Radiol. 1994 Jun;29 Suppl 2:S157-60. doi: 10.1097/00004424-199406001-00052. No abstract available.

  PMID: 7928216 BACKGROUND

• Ahlman MA, Raman FS, Penzak SR, Pang J, Fan Z, Liu S, Gai N, Li D, Bluemke DA. Part 1 - Coronary angiography with gadofosveset trisodium: a prospective feasibility study evaluating injection techniques for steady-state imaging. BMC Cardiovasc Disord. 2015 Dec 22;15:177. doi: 10.1186/s12872-015-0176-0.

  PMID: 26695065 DERIVED

• Raman FS, Nacif MS, Cater G, Gai N, Jones J, Li D, Sibley CT, Liu S, Bluemke DA. 3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium. Int J Cardiovasc Imaging. 2013 Jun;29(5):1085-94. doi: 10.1007/s10554-013-0192-z. Epub 2013 Mar 21.

  PMID: 23515949 DERIVED

Related Links

• NIH Clinical Center Detailed Web Page

Study Officials

• Bernadette A Redd, M.D.

  National Institutes of Health Clinical Center (CC)

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Tracy L Cropper, R.N.

CONTACT

(301) 402-6132; tcropper@cc.nih.gov

Bernadette A Redd, M.D.

CONTACT

(301) 215-0785; bernadette.redd@nih.gov

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: NIH
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 25, 2010
• First Posted: May 26, 2010
• Study Start: June 5, 2010
• Last Updated: April 29, 2026

Record last verified: 2025-12-18

Locations

US (1)